Ciencia Group, LLC has extensive expertise in providing high quality and cost-effective strategies for preclinical development for the pharmaceutical and biotechnology industries. In addition, Ciencia Group has a proven track record of designing and implementing studies and preparing IND, NDA and CTD documents that resulted in the initiation of human clinical trails and FDA approval for both small molecule and protein drugs.